Direct reprogramming of mouse fibroblasts into cardiac myocytes

Kohei Inagawa, Masaki Ieda

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The potency of specific transcription factors as cell fate determinants was first demonstrated by the discovery of MyoD, a master gene for skeletal muscle transdifferentiation. More recently, the induction of pluripotency in somatic cells using a combination of stem cell-specific transcription factors has been reported. That elegant study altered the approach to regenerative medicine and inspired new strategies for generating specific cell types by introducing combinations of lineage-specific transcription factors. A diverse range of cell types, such as pancreatic β-cells, neurons, chondrocytes, and hepatocytes, can be induced from heterologous cells using lineage-specific reprogramming factors. Furthermore, functional cardiomyocytes can be generated directly from differentiated somatic cells using several combinations of cardiac-enriched defined factors in the mouse. The present article reviews the pioneering and recent studies in cellular reprogramming and discusses the perspectives and challenges of direct cardiac reprogramming in regenerative therapy.

Original languageEnglish
Pages (from-to)37-45
Number of pages9
JournalJournal of Cardiovascular Translational Research
Volume6
Issue number1
DOIs
Publication statusPublished - 2013 Feb 1

Keywords

  • Cardiac regeneration
  • Direct reprogramming
  • Heart
  • Induced cardiomyocytes
  • Stem cell

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmaceutical Science
  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Direct reprogramming of mouse fibroblasts into cardiac myocytes'. Together they form a unique fingerprint.

  • Cite this